MediciNova

MediciNova

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.16-$1.96
Market Cap
$65.9M
Shares Short
310,377

Financials

See more
Revenue (12 Mos)
$596,641
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$47,934
Diluted EPS
-$0.24

News

See more

Yahoo Finance • 18 days ago

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

Yahoo Finance • last month

MediciNova CEO Provides Shareholder Update

Yahoo Finance • 2 months ago

Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight

Yahoo Finance • 2 months ago

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

About

CEO
Dr. Yuichi Iwaki M.D., Ph.D.
CFO
Mr. Jason J. Kruger CPA
Address
4275 Executive Square, La Jolla, CA, United States, 92037
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
6